C28H28D8N4O3S
Neat
516.74
Lurasidone Metabolite 14326 D8; 2070009-33-3; (1S, 2S, 6R, 7S, 8S)-4-[[(1R, 2R)-2-[[4-(1, 2-benzothiazol-3-yl)-2, 2, 3, 3, 5, 5, 6, 6-octadeuteriopiperazin-1-yl]methyl]cyclohexyl]methyl]-8-hydroxy-4-azatricyclo[5.2.1.02, 6]decane-3, 5-dione; 5a/6a-Hydroxy Lurasidone-D8; orb1987488; orb2280881; HY-G0002S; AKOS037652734; ES-2493; Lurasidone Inactive Metabolite 14326-d8; (3aR, 4S, 5S, 7S, 7aS)-2-(((1R, 2R)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl-2, 2, 3, 3, 5, 5, 6, 6-d8)methyl)cyclohexyl)methyl)-5-hydroxyhexahydro-1H-4, 7-methanoisoindole-1 and 3(2H)-dione
(1S, 2S, 6R, 7S, 8S)-4-[[(1R, 2R)-2-[[4-(1, 2-benzothiazol-3-yl)-2, 2, 3, 3, 5, 5, 6, 6-octadeuteriopiperazin-1-yl]methyl]cyclohexyl]methyl]-8-hydroxy-4-azatricyclo[5.2.1.02, 6]decane-3 and 5-dione
InChI=1S/C28H36N4O3S/c33-22-14-19-13-21(22)25-24(19)27(34)32(28(25)35)16-18-6-2-1-5-17(18)15-30-9-11-31(12-10-30)26-20-7-3-4-8-23(20)36-29-26/h3-4,7-8,17-19,21-22,24-25,33H,1-2,5-6,9-16H2/t17-,18-,19-,21+,22-,24-,25+/m0/s1/i9D2,10D2,11D2,12D2